These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody]. Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545 [TBL] [Abstract][Full Text] [Related]
10. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353 [TBL] [Abstract][Full Text] [Related]
11. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031 [TBL] [Abstract][Full Text] [Related]
12. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637 [TBL] [Abstract][Full Text] [Related]
14. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells. Valmori D; Qian F; Ayyoub M; Renner C; Merlo A; Gnjatic S; Stockert E; Driscoll D; Lele S; Old LJ; Odunsi K Clin Cancer Res; 2006 Jan; 12(2):398-404. PubMed ID: 16428478 [TBL] [Abstract][Full Text] [Related]
15. WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma. van Amerongen RA; Hagedoorn RS; Remst DFG; Assendelft DC; van der Steen DM; Wouters AK; van de Meent M; Kester MGD; de Ru AH; Griffioen M; van Veelen PA; Falkenburg JHF; Heemskerk MHM J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728869 [TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. Milne K; Barnes RO; Girardin A; Mawer MA; Nesslinger NJ; Ng A; Nielsen JS; Sahota R; Tran E; Webb JR; Wong MQ; Wick DA; Wray A; McMurtrie E; Köbel M; Kalloger SE; Gilks CB; Watson PH; Nelson BH PLoS One; 2008; 3(10):e3409. PubMed ID: 18923710 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K. Hee Lee J; Park MS; Hwang JE; Cho SH; Bae WK; Shim HJ; Kim DE; Chung IJ Cell Mol Immunol; 2013 May; 10(3):275-82. PubMed ID: 23524651 [TBL] [Abstract][Full Text] [Related]